Yanhua Ding

Jilin University (JLU) - Phase I Clinical Research Center

China

SCHOLARLY PAPERS

1

DOWNLOADS

26

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Phase I Randomized Study of a Novel HBV Capsid Assembly Modulator, ALG-000184, in Participants with Chronic HBV Infection: Effects on Safety, HBV DNA and HBsAg Levels

Number of pages: 36 Posted: 23 Apr 2025
The University of Hong Kong - Li Ka Shing Faculty of Medicine, King’s College London - Institute of Liver Studies, ARENSIA Exploratory Medicine, Southern Medical University - State Key Laboratory of Organ Failure Research, Jilin University (JLU) - First Hospital, Jilin University (JLU) - Phase I Clinical Research Center, ARENSIA Exploratory Medicine, Southern Medical University, Jilin University (JLU), Aligos Therapeutics Inc, Aligos Therapeutics Inc, Aligos Therapeutics Inc, Aligos Therapeutics Inc, Aligos Therapeutics Inc, affiliation not provided to SSRN and University of Auckland
Downloads 26 (1,089,447)

Abstract:

Loading...

HBV, CAM, HBsAg, Functional Cure, HBV RNA